Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Colombia: leading pharma companies by sales 2016

Leading pharmaceutical companies by sales in Colombia in 2016 (in million U.S. dollars)

by Statista Research Department, last edited Dec 15, 2016
Colombia: leading pharma companies by sales 2016 This statistic shows the leading pharmaceutical companies in Colombia based on 2016 sales, in million U.S. dollars. In that year, some 335 million U.S. dollars in sales were generated by French pharma company Sanofi, whereas the local pharmaceutical company Procaps had sales of 106 million U.S. dollars.
Show more

Leading pharmaceutical companies by sales in Colombia in 2016 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.